Health Canada expands Ozempic approval to include reducing the risk of heart attacks and strokes in adults with type 2 diabetes and heart or kidney disease.
Heart & Stroke report reveals 90% of Canadians have at least one risk factor for heart disease. Learn about the new data on hypertension, diabetes, and vaping.